Tocilizumab and Alcohol/Food Interactions
There is 1 alcohol/food/lifestyle interaction with tocilizumab.
Moderate
Tocilizumab High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia)
Moderate Potential Hazard, Moderate plausibility
tocilizumab - lipid abnormalities
Tocilizumab treatment was associated with increases in lipid parameters (e.g., total cholesterol, triglycerides, low-density lipoprotein [LDL] cholesterol, and/or high-density lipoprotein [HDL] cholesterol). Lipid parameters should be assessed about 4 to 8 weeks after initiation of therapy. Patients should be managed according to clinical guidelines for the management of hyperlipidemia.
Tocilizumab drug interactions
There are 333 drug interactions with tocilizumab.
Tocilizumab disease interactions
There are 8 disease interactions with tocilizumab which include:
- infections
- tuberculosis
- demyelinating disorders
- gastrointestinal perforation
- lipid abnormalities
- liver dysfunction
- neutropenia/thrombocytopenia
- renal impairment
Report options
QR code containing a link to this page
More about tocilizumab
- tocilizumab consumer information
- Check interactions
- Compare alternatives
- Reviews (53)
- Side effects
- Dosage information
- During pregnancy
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
